Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
The novel rheumatoid arthritis biologic partnered by...
WuXi AppTec, China's largest CRO/CMO,...
WuXi AppTec, China's largest CRO/CMO,...
WuXi Biologics, the biologics arm of...
SynTheAll (STA) Pharma, WuXi AppTec's...
Wuxi AppTec, China's largest CRO/CMO,...
WuXi NextCODE, the contract genomics arm...
Two prominent China-US healthcare investment firms plan...
According to a Reuters report, WuXi...
According to sources, the upcoming Hong Kong IPO for...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China